Sintx Technologies (SINT) Operating Income Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45% |
| Dec 31, 2025 | 36.75% |
| Sep 30, 2025 | -6.68% |
| Jun 30, 2025 | -6.08% |
| Mar 31, 2025 | -5.15% |
| Dec 31, 2024 | -1.09% |
| Sep 30, 2024 | -30.39% |
| Jun 30, 2024 | -12.23% |
| Mar 31, 2024 | -13.07% |
| Dec 31, 2023 | -17.94% |
| Sep 30, 2023 | 13.27% |
| Jun 30, 2023 | -12.74% |
| Mar 31, 2023 | -9.78% |
| Dec 31, 2022 | -26.58% |
| Sep 30, 2022 | -7.19% |
| Jun 30, 2022 | -10.05% |
| Mar 31, 2022 | -9.83% |
| Dec 31, 2021 | 4.97% |
| Sep 30, 2021 | 2.50% |
| Jun 30, 2021 | 1.13% |
| Mar 31, 2021 | -2.72% |
| Dec 31, 2020 | 3.20% |
| Sep 30, 2020 | 2.85% |
| Jun 30, 2020 | 5.24% |
| Mar 31, 2020 | 14.28% |
| Dec 31, 2019 | 15.66% |
| Sep 30, 2019 | 21.32% |
| Jun 30, 2019 | 32.21% |
| Mar 31, 2019 | 15.67% |
| Dec 31, 2018 | 39.92% |
| Sep 30, 2018 | -29.55% |
| Jun 30, 2018 | 6.59% |
| Mar 31, 2018 | 4.26% |